Director, MSAT
Lyell ImmunopharmaBothell, Washington, United States
Posted October 27, 2025
195000 - 240000 USD year
Full Time
About the Company
Lyell Immunopharma is a clinical-stage biotech company advancing next-generation CAR T-cell therapies for solid tumors and hematologic malignancies. Our product candidates leverage novel technology to enhance T-cell durability and efficacy, aiming for consistent long-lasting clinical responses. Founded by cell therapy pioneers, Lyell operates as a fully integrated entity from discovery to clinical evaluation, driven by values of Science, Respect, Collaboration, and Courage.
Job Description
Lyell is a clinical-stage company focused on advancing next-generation CAR T-cell therapies for solid tumors or hematologic malignancies. They are seeking a Director of MSAT to lead the Manufacturing Science and Technology group, responsible for overseeing technical oversight of viral vector and cell therapies, ensuring adherence to quality standards, and supporting clinical trial manufacturing activities. The company is built on a science-based approach and values collaboration, resilience, and innovation.
Requirements
- Experience in supporting GMP biopharmaceutical manufacturing for cell or gene therapy (5+ years)
- BS/BSc in biochemistry, chemical engineering, bioengineering, or related field (15+ years exp.)
- MBA/MSc in biochemistry, chemical engineering, bioengineering, or related field (10+ years exp.)
- Working knowledge of regulatory requirements for GMP manufacturing of drug substance, drug products, cellular and gene therapies
- Strong leadership and communication skills
- Experience with manufacturing automation and MES systems
Benefits
- Subsidized medical, dental and vision plans
- FSA
- Company provided Life and AD&D Insurance as well as STD and LTD Insurance
- EspP
- Mobile communication benefits
- Supplemental benefits
